The planned research will adapt an intervention of known efficacy to target a new outcome of significant importance to public health. Specifically the Community Reinforcement and Family Training (CRAFT) procedures will be adapted, from reinforcing treatment entry, to reinforcing treatment retention and HIV risk behavior reduction in persons with opioid dependence who receive a Buprenorphine taper detoxification. The research plan includes three phases: 1) development of a manual guided therapy, 2) development of therapist training and fidelity measures and 3) a randomized pilot evaluation with 52 patients receiving either the new CRAFT treatment or treatment as usual.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
104
The Community Reinforcement and Family Training for Treatment Retention and HIV Risk Reduction treatment (CRAFT-T) was be developed in phase 1 and 2 of the current study and consists of twelve manual-guided weekly one-hour individual sessions for the concerned significant other and 2 one hour sessions for the identified patient. The intervention also allows for up to two additional sessions (total of 14 visits) to help arrange re-entry into substance abuse treatment when needed. The identified patient receives this intervention in addition to the usual services at the drug treatment program (Maryhaven).
Treatment as usual will be the normal course of treatment for concerned significant others (CSOs) in the outpatient department.
Maryhaven
Columbus, Ohio, United States
The primary outcome is retention in drug abuse treatment, specifically time to first drop from services for at least 3 weeks duration.
Time frame: 6 months
The Identified Patient's engagement in behaviors that increase the risk of contracting HIV, as measured by the RAB
Time frame: 6 months
The concerned significant other's (CSO's) engagement in behaviors that increase the risk of contracting HIV, as measured by the RAB,
Time frame: 6 months
The identified patient's successful completion of drug abuse treatment episode
Time frame: 6 months
The portion of available treatment sessions attended during each assessment period including,
Time frame: 6 months
Substance use (defined as days of self-reported substance use, with partial confirmation by urinalysis and breathalyzer) during the active study phase and through the 3 month and 6-month follow-ups.
Time frame: 6 months
The identified patient's substance use as reported by the CSO (collateral reports of drug use).
Time frame: 6 months
Changes in concerned significant other and identified patient function as measured using the Brief Symptom Inventory. Specifically, the Global Severity Index (GSI) score.
Time frame: 6 months
Concerned significant other and identified patient's relationship satisfaction (the score on the General Happiness Scale of the RHS).
Time frame: 6 months
Marital satisfaction as measured by the KMS for the sub-sample of concerned significant others who are married to their identified patient's.
Time frame: 6 months
The identified patient's (IP) retention in any substance abuse specific intervention, including self-help, as reported by the IP on the Treatment tracking form.
Time frame: 6 months
The identified patient's retention in any substance abuse specific intervention, including self-help, as reported by CSO on the Treatment Tracking form.
Time frame: 6 months
Identified patient (IP) attendance at self-help groups (i.e., AA, NA, CA) (defined as the number of times that the IP has attended a self-help group as assessed on the Treatment Services Review).
Time frame: 6 months
Identified patient's use of professional services, other than substance abuse treatment, as reported on the TSR.
Time frame: 6 months
Concerned significant others satisfaction with treatment as measured by the Participant Satisfaction Form.
Time frame: 3 months
Identified patient's satisfaction with treatment as measured by the Participant Satisfaction
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.